Human leucocyte antigen alleles and haplotypes and their associations with antinuclear antibodies features in Chinese patients with primary biliary cirrhosis

Liver International

Volumn 34, Issue 2, 2014, Pages 220-226

  Zhao, Dan Tong ^a   Liao, Hui Yu ^a   Zhang, Xin ^a   Liu, Yan Min ^a   Zhao, Yan ^a   Zhang, Hai Ping ^a   Sun, Li Mei ^a   Ma, Yin Xue ^a   Yan, Hui Ping ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Anti gp210 antibody; Antinuclear antibody; Genetic susceptibility; Human leucocyte antigen; Primary biliary cirrhosis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; GLYCOPROTEIN GP 120 ANTIBODY; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; HAPLOTYPE; HISTOPATHOLOGY; HLA TYPING; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIMARY BILIARY CIRRHOSIS;

ANTI-GP210 ANTIBODY; ANTINUCLEAR ANTIBODY; GENETIC SUSCEPTIBILITY; HUMAN LEUCOCYTE ANTIGEN; PRIMARY BILIARY CIRRHOSIS;

ADULT; AGED; ALLELES; ANTIBODIES, ANTINUCLEAR; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-A ANTIGENS; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; ODDS RATIO;

EID: 84891824703     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12236     Document Type: Article

References (38)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-73.
2. Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987; 138: 3525-31.
3. Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J. Antinuclear antibodies in primary biliary cirrho-sis. Semin Liver Dis 2005; 25: 298-310.
4. Nakamura M, Shimizu-Yoshida Y, Takii Y, et al. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol 2005; 42: 386-92.
5. Nakamura M, Kondo H, Mori T, et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 2007; 45: 118-27.
6. Invernizzi P, Selmi C, Mackay IR, Podda M, Gershwin ME. From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2005; 3: 401-10.
7. Brind AM, Bray GP, Portmann BC, Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut 1995; 36: 615-7.
8. Donaldson PT. Genetics of liver disease: immunogenetics and disease pathogenesis. Gut 2004; 53: 599-608.
9. Tanaka A, Borchers AT, Ishibashi H, et al. Genetic and familial considerations of primary biliary cirrhosis. Am J Gastroenterol 2001; 96: 8-15.
10. Liu X, Invernizzi P, Lu Y, et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 2010; 42: 658-60.
11. Mells GF, Floyd JA, Morley KI, et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet 2011; 43: 329-32.
12. Wassmuth R, Depner F, Danielsson A, et al. HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis. Tissue Antigens 2002; 59: 381-7.
13. Donaldson PT, Baragiotta A, Heneghan MA, et al. HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology 2006; 44: 667-74.
14. Mullarkey ME, Stevens AM, McDonnell WM, et al. Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis. Tissue Antigens 2005; 65: 199-205.
15. Invernizzi P, Selmi C, Poli F, et al. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology 2008; 48: 1906-12.
16. Onishi S, Sakamaki T, Maeda T, et al. DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliar y cirrhosis. J Hepatol 1994; 21: 1053-60.
17. Nakamura M, Yasunami M, Kondo H, et al. Analysis of HLA-DRB1 polymorphisms in Japanese patients with primary biliary cirrhosis (PBC): The HLA-DRB1polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC. Hepatol Res 2010; 40: 494-504.
18. Umemura T, Joshita S, Ichijo T, et al. Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis. Hepatology 2012; 55: 506-11.
19. Liu HY, Deng AM, Zhou Y, et al. Analysis of HLA alleles polymorphism in Chinese patients with primary biliary cirrhosis. Hepatobiliary Pancreat Dis Int 2006; 5: 129-32.
20. Lindor KD, Gershwin ME, Poupon R, et al., American Association for Study of Liver Diseases. Primary biliary cirrhosis. Hepatology 2009; 50: 291-308.
21. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51: 237-67.
22. Bowtell DD. Rapid isolation of eukaryotic DNA. Anal Biochem 1987; 162: 463-5.
23. Holdsworth R, Hurley CK, Marsh SG, et al. The HLA dictionary 2008: a summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Tissue Antigens 2009; 73: 95-170.
24. Marsh SG, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens 2010; 75: 291-455.
25. Gores GJ, Moore SB, Fisher LD, Powell FC, Dickson ER. Primary biliary cirrhosis: associations with class II major histocompatibility complex antigens. Hepatology 1987; 7: 889-92.
26. Underhill J, Donaldson P, Bray G, et al. Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype. Hepatology 1992; 16: 1404-8.
27. Begovich AB, Klitz W, Moonsamy PV, et al. Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens 1994; 43: 71-7.
28. Gregory WL, Mehal W, Dunn AN, et al. Primary biliary cirrhosis: contribution of HLA class II allele DR8. Q J Med 1993; 86: 393-9.
29. Manns MP, Bremm A, Schneider PM, et al. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology 1991; 101: 1367-73.
30. Wassmuth R, Depner F, Danielsson A, et al. HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis. Tissue Antigens 2002; 59: 381-7.
31. Donaldson PT, Baragiotta A, Heneghan MA, et al. HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology 2006; 44: 667-74.
32. Invernizzi P, Battezzati PM, Crosignani A, et al. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol 2003; 38: 401-6.
33. Miyamori H, Kato Y, Kobayashi K, Hattori N. HLA antigens in Japa-nese patients with primary biliary cirrhosis and autoimmune hepatitis. Digestion 1983; 26: 213-7.
34. Bassendine MF, Dewar PJ, James OF. HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut 1985; 26: 625-8.
35. Briggs DC, Donaldson PT, Hayes P, et al. A major histocompatibility complex class III allotype (C4B 2) associated with primar y biliar y cirrhosis (PBC). Tissue Antigens 1987; 29: 141-5.
36. Manns MP, Bremm A, Schneider PM, et al. HLA DRw8 and complement C4 deficiency as risk factors in primar y biliar y cirrhosis. Gastroenterology 1991; 101: 1367-73.
37. Hov JR, Lleo A, Selmi C, et al. Genetic associations in Italian primary sclerosing cholangitis: heteroge-neity across Europe defines a critical role for HLA-C. J Hepatol 2010; 52: 712-7.
38. Hirschfield GM, Liu X, Xu C, et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009; 360: 2544-55.